News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
618,638 Results
Type
Article (47649)
Company Profile (168)
Press Release (570821)
Section
Business (174473)
Career Advice (2783)
Deals (31878)
Drug Delivery (94)
Drug Development (76453)
Employer Resources (166)
FDA (16396)
Job Trends (14013)
News (308433)
Policy (32078)
Tag
Academia (2654)
Alliances (46751)
Alzheimer's disease (1282)
Approvals (16341)
Artificial intelligence (144)
Bankruptcy (331)
Best Places to Work (11252)
Biotechnology (112)
Breast cancer (178)
Cancer (1333)
Cardiovascular disease (104)
Career advice (2336)
Cell therapy (286)
Clinical research (61175)
Collaboration (476)
Compensation (153)
COVID-19 (2521)
C-suite (112)
Data (1362)
Diabetes (176)
Diagnostics (5710)
Earnings (63627)
Employer resources (147)
Events (84476)
Executive appointments (392)
FDA (17100)
Funding (424)
Gene therapy (202)
GLP-1 (575)
Government (4504)
Healthcare (18139)
Infectious disease (2617)
Inflammatory bowel disease (109)
Interviews (527)
IPO (14602)
Job creations (3159)
Job search strategy (1945)
Layoffs (370)
Legal (6875)
Lung cancer (193)
Manufacturing (210)
Medical device (11869)
Medtech (11873)
Mergers & acquisitions (17432)
Metabolic disorders (455)
Neuroscience (1621)
NextGen Class of 2024 (6485)
Non-profit (4906)
Northern California (1508)
Obesity (255)
Opinion (222)
Parkinson's disease (100)
Patents (119)
People (51790)
Phase I (18862)
Phase II (26990)
Phase III (20358)
Pipeline (507)
Postmarket research (2289)
Preclinical (7924)
Radiopharmaceuticals (228)
Rare diseases (287)
Real estate (5056)
Regulatory (22206)
Research institute (2436)
Resumes & cover letters (452)
Southern California (1342)
Startups (3241)
United States (13928)
Vaccines (585)
Weight loss (180)
Date
Today (1)
Last 7 days (261)
Last 30 days (2079)
Last 365 days (33018)
2024 (32945)
2023 (37278)
2022 (47937)
2021 (52313)
2020 (51481)
2019 (45186)
2018 (34287)
2017 (30533)
2016 (29495)
2015 (34028)
2014 (26458)
2013 (22345)
2012 (23910)
2011 (24538)
2010 (22776)
Location
Africa (858)
Arizona (130)
Asia (37465)
Australia (6212)
California (3409)
Canada (1386)
China (304)
Colorado (166)
Connecticut (184)
Europe (82643)
Florida (510)
Georgia (119)
Illinois (398)
Indiana (215)
Maryland (607)
Massachusetts (2618)
Michigan (166)
Minnesota (227)
New Jersey (1062)
New York (1031)
North Carolina (687)
Northern California (1508)
Ohio (146)
Pennsylvania (828)
South America (1157)
Southern California (1342)
Texas (521)
Utah (105)
Washington State (368)
618,638 Results for "national organization for rare disorders".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tracey Sikora Joins the National Organization for Rare Disorders (NORD®) as Vice President of Research & Clinical Programs
December 12, 2024
·
3 min read
Press Releases
National Organization for Rare Disorders (NORD) Launches the Living Rare Study - First to Measure Full Scope of Rare Disease Challenges
October 22, 2024
·
3 min read
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
Pharming Group N.V. is pleased to announce its recognition as an Industry Innovator by the National Organization for Rare Disorders at the Rare Impact Awards on June 8, 2024.
April 24, 2024
·
8 min read
Press Releases
National Organization for Rare Disorders (NORD) Announces $85,000 in Grant Funding for Amyloidosis and Levy-Yeboa Syndrome
October 1, 2024
·
2 min read
Genetown
National Organization for Rare Disorders (NORD) Releases Annual State Report Card, Revealing Trends in Rare Disease Health Care Coverage
The National Organization for Rare Disorders released its annual State Report Card, which grades each U.S. state on critical issues impacting access to care for the 1 in 10 Americans living with a rare disease.
March 6, 2024
·
4 min read
BioCapital
National Organization for Rare Disorders Launches Education Series to Advance Patient Involvement in Rare Disease Drug Development
The National Organization for Rare Disorders launched a new education series in English and Spanish titled, “Rare Disease Drug Development: What Patients and Advocates Need to Know,” designed to help patients and patient advocacy groups understand the drug development process.
October 16, 2023
·
4 min read
Pharm Country
National Organization for Rare Disorders Announces More Than $100,000 in Grant Funding Available for Rare Disease Research
The National Organization for Rare Disorders announced three new grant funding opportunities related to the following rare diseases: Arteriovenous Malformation, Levy-Yeboa Syndrome, and Megacystis Microcolon Intestinal Hypoperistalsis Syndrome.
September 19, 2023
·
2 min read
Press Releases
Orsini chosen by Ascendis to distribute treatment for rare endocrine disorder in the U.S.
December 9, 2024
·
1 min read
Pharm Country
Coalition to Cure Calpain 3 in Partnership with the National Organization for Rare Disorders (NORD®) Launches LGMD2A/Calpainopathy Registry
Coalition to Cure Calpain 3 in partnership with the National Organization for Rare Disorders launched a study with global reach to research Calpainopathy, a rare form of muscular dystrophy that causes progressive muscle weakness and wasting.
September 21, 2023
·
3 min read
Press Releases
Novo Nordisk to present new data highlighting innovative rare blood disorders pipeline at ASH 2024
December 4, 2024
·
10 min read
1 of 61,864
Next
